Showing results (1691-1700 of 10,442) with videos related to
Sort By:
Pageof 1,045
AIDS (London, England)|May 21, 2005
Relationship of CD4+CD25+ regulatory T cells to immune status in HIV-infected patientsSachi Tsunemi, Tsuyoshi Iwasaki, Takehito Imado, et al.AIDS (London, England)|May 21, 2005
Soluble HIV-1 gp120 enhances HIV-1 replication in non-dividing CD4+ T cells, mediated via cell signaling and Tat cofactor overexpressionDorothée Missé, Johanna Gajardo, Christelle Oblet, et al.AIDS (London, England)|May 21, 2005
The effect of HIV infection on overdose mortalityCunlin Wang, David Vlahov, Noya Galai, et al.AIDS (London, England)|May 4, 2005
Nelfinavir and nevirapine side effects during pregnancySarah Timmermans, Claire Tempelman, Mieke H Godfried, et al.AIDS (London, England)|May 4, 2005
Severity and outcome of HIV-associated Pneumocystis pneumonia containing Pneumocystis jirovecii dihydropteroate synthase gene mutationsKristina Crothers, Charles B Beard, Joan Turner, et al.AIDS (London, England)|May 4, 2005
Couple-focused support to improve HIV medication adherence: a randomized controlled trialRobert H Remien, Michael J Stirratt, Curtis Dolezal, et al.AIDS (London, England)|May 4, 2005
Declining risk of triple-class antiretroviral drug failure in Danish HIV-infected individualsNicolai Lohse, Niels Obel, Gitte Kronborg, et al.AIDS (London, England)|May 4, 2005
Evolution of resistance mutations pattern in HIV-1-infected patients during intensification therapy with a boosted protease inhibitorJosé L Blanco, M Alejandra Biglia, Mireia Arnedo, et al.AIDS (London, England)|August 17, 2005
Cost effectiveness and delivery study for future HIV vaccinesD C Barth-Jones, H Cheng, L Y Kang, et al.AIDS (London, England)|August 17, 2005
The normalized inhibitory quotient of boosted protease inhibitors is predictive of viral load response in treatment-experienced HIV-1-infected individualsAlan Winston, Gill Hales, Janaki Amin, et al.Pageof 1,045